Last reviewed · How we verify

guided injection of Triamcinolone

Complejo Hospitalario Universitario de Granada · FDA-approved active Small molecule Quality 5/100

guided injection of Triamcinolone is a Small molecule drug developed by Complejo Hospitalario Universitario de Granada. It is currently FDA-approved. Also known as: guided perineural injection.

At a glance

Generic nameguided injection of Triamcinolone
Also known asguided perineural injection
SponsorComplejo Hospitalario Universitario de Granada
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about guided injection of Triamcinolone

What is guided injection of Triamcinolone?

guided injection of Triamcinolone is a Small molecule drug developed by Complejo Hospitalario Universitario de Granada.

Who makes guided injection of Triamcinolone?

guided injection of Triamcinolone is developed and marketed by Complejo Hospitalario Universitario de Granada (see full Complejo Hospitalario Universitario de Granada pipeline at /company/complejo-hospitalario-universitario-de-granada).

Is guided injection of Triamcinolone also known as anything else?

guided injection of Triamcinolone is also known as guided perineural injection.

What development phase is guided injection of Triamcinolone in?

guided injection of Triamcinolone is FDA-approved (marketed).

Related